UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036793
Receipt number R000041924
Scientific Title Clinical data over long term with sitagliptin treatment for type 2 diabetes patients in our hospital
Date of disclosure of the study information 2019/05/19
Last modified on 2020/01/16 08:45:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical data over long term with sitagliptin treatment for type 2 diabetes patients in our hospital

Acronym

Clinical data over long term with sitagliptin treatment for type 2 diabetes patients in our hospital

Scientific Title

Clinical data over long term with sitagliptin treatment for type 2 diabetes patients in our hospital

Scientific Title:Acronym

Clinical data over long term with sitagliptin treatment for type 2 diabetes patients in our hospital

Region

Japan


Condition

Condition

type 2 diabetes mellitus

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Administration of sitagliptin is expected not only to improve blood glucose but also to have a renal protection effect. However, there are not many reports on the long-term effects of sitagliptin in Japan.Therefore, we explore the effects on glycemic control and renal protection effect in patients with type 2 diabetes treated with sitagliptin for more than 5years.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

HbA1c, Urinary albumin

Key secondary outcomes

1. Efficacy and safety of sitagliptin single use
2. Safety in the elderly
3. Safety of patients using insulin


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Outpatients
2) over 20 years old
3) T2DM
4) eGFR over 30 mL/min/1.73 m2
5) Diet and exercise therapies are well performed
6) Patients who are suspected good-compliant
7) Understanding of the study procedures and agreement to participate in the study, by giving written informed consent

Key exclusion criteria

1) Patients suspected of having secondary diabetes (ex. endocrine disease, drug-induced or liver disease)
2) Females who are pregnant or who intend to become pregnant within the study
3) Severe hepatic disease, malignancy, a history of gastrectomy and/or positive for HIV
4) Contraindication with sitagliptin
5) Patient who disqualified from the study by the investigator for any reason other than given above.

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Yasuhiro
Middle name
Last name Iijima

Organization

Tokyo Medical University

Division name

Department of Diabetes, Endocrinology and Metabolism

Zip code

160-0023

Address

6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo

TEL

03-3342-6111

Email

yasuhiro.iijima1203@gmail.com


Public contact

Name of contact person

1st name Yasuhiro
Middle name
Last name Iijima

Organization

Manda Memorial Hospital

Division name

Diabetes Center

Zip code

060-0062

Address

Minami 2, Nishi 1, Chuo-ku, Sapporo

TEL

011-231-4032

Homepage URL


Email

yasuhiro.iijima1203@gmail.com


Sponsor or person

Institute

Manda memorial hospital

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Manda Memorial Hospital

Address

Minami 2, Nishi 1, Chuo-ku, Sapporo

Tel

011-231-4032

Email

yasuhiro.iijima1203@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

萬田記念病院(北海道)


Other administrative information

Date of disclosure of the study information

2019 Year 05 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

400

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 12 Month 01 Day

Date of IRB

2019 Year 04 Month 19 Day

Anticipated trial start date

2018 Year 12 Month 01 Day

Last follow-up date

2019 Year 04 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study examines the retrospective effectiveness of medical records from patients with type 2 diabetes mellitus during outpatient visits to our hospital who have been dosed with sitagliptin during 2009-2013. Evaluation items are determined on the basis of HbA1c, microalbuminuria, and progression of complications. Statistical analysis is performed on the obtained data to evaluate the effect. And we will consider the secondary effects from the following three points.
(1) Patients who continued to use sitagliptin alone, (2) elderly patients aged 65 years or older, and (3) patients with combined insulin


Management information

Registered date

2019 Year 05 Month 19 Day

Last modified on

2020 Year 01 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041924


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name